Chambers C, Watakul S, Schofield P, Howell A, Zhu J, Tran A
Sci Adv. 2025; 11(11):eadq4416.
PMID: 40073121
PMC: 11900870.
DOI: 10.1126/sciadv.adq4416.
Khizar H, Ali K, Wang J
Cancer Immunol Immunother. 2025; 74(4):121.
PMID: 39998578
PMC: 11861851.
DOI: 10.1007/s00262-025-03965-w.
Verona F, Di Bella S, Schirano R, Manfredi C, Angeloro F, Bozzari G
Front Immunol. 2025; 16:1529847.
PMID: 39981232
PMC: 11839637.
DOI: 10.3389/fimmu.2025.1529847.
Peeney D, Kumar S, Singh T, Liu Y, Jensen S, Chowdhury A
Transl Oncol. 2025; 53:102309.
PMID: 39904284
PMC: 11846589.
DOI: 10.1016/j.tranon.2025.102309.
Liu M, Wang C, Hu Q, Wu X, Wang Q, Wang J
Transl Oncol. 2025; 53:102287.
PMID: 39837060
PMC: 11788856.
DOI: 10.1016/j.tranon.2025.102287.
Immune Microenvironment in Breast Cancer Metastasis.
Qian B, Ma R
Adv Exp Med Biol. 2025; 1464():413-432.
PMID: 39821036
DOI: 10.1007/978-3-031-70875-6_20.
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma.
Liao R, Wang J, Zhang F, Fang Y, Zhou L, Zhang Y
Sci Rep. 2025; 15(1):1404.
PMID: 39789247
PMC: 11717914.
DOI: 10.1038/s41598-025-85537-7.
Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention.
Contursi A, Tacconelli S, Di Berardino S, De Michele A, Patrignani P
Front Pharmacol. 2025; 15:1520488.
PMID: 39764464
PMC: 11701038.
DOI: 10.3389/fphar.2024.1520488.
Tubulin-Based Microtentacles Aid in Heterotypic Clustering of Neutrophil-Differentiated HL-60 Cells and Breast Tumor Cells.
Ju J, Thompson K, Annis D, Mull M, Gilchrist D, Moriarty A
Adv Sci (Weinh). 2024; 12(6):e2409260.
PMID: 39696759
PMC: 11809343.
DOI: 10.1002/advs.202409260.
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials.
Zoghbi M, Patel B, Roulleaux Dugage M, Mezquita L, Bahleda R, Dufresne A
Cancers (Basel). 2024; 16(23).
PMID: 39682239
PMC: 11640131.
DOI: 10.3390/cancers16234053.
Reversal of postoperative breast cancer metastasis by the use of embedded hydrogel.
Yu Z, Chi W, Wang C, Qiu Y, Qiu Z, Zhu W
Am J Transl Res. 2024; 16(11):6991-7015.
PMID: 39678538
PMC: 11645627.
DOI: 10.62347/VZAW2270.
Real-time imaging reveals a role for macrophage protrusive motility in melanoma invasion.
Ramakrishnan G, Miskolci V, Hunter M, Giese M, Munch D, Hou Y
J Cell Biol. 2024; 224(2.
PMID: 39570286
PMC: 11586626.
DOI: 10.1083/jcb.202403096.
PD-L1 promotes tumor metastasis by regulating the infiltration of FGFBP2(+)Tm cells in colorectal cancer.
Zhuang M, Liu J, Li Y, Zhang J, Jiang Z, Wang X
Oncogene. 2024; 44(6):378-390.
PMID: 39558101
DOI: 10.1038/s41388-024-03223-w.
Engineering an αCD206-synNotch Receptor: Insights into the Development of Novel Synthetic Receptors.
Semeniuk S, Qian B, Cachat E
ACS Synth Biol. 2024; 13(12):3876-3884.
PMID: 39555579
PMC: 11669160.
DOI: 10.1021/acssynbio.4c00149.
The oncogenic functions of SPARCL1 in bladder cancer.
Li C, Yuan H, Chen J, Shang K, He H
J Cell Mol Med. 2024; 28(22):e70196.
PMID: 39548034
PMC: 11567778.
DOI: 10.1111/jcmm.70196.
Multi-omics analysis of the biological function of the VEGF family in colon adenocarcinoma.
Yang J, Li C, Wang Z, Jiang K
Funct Integr Genomics. 2024; 24(6):210.
PMID: 39527375
PMC: 11554882.
DOI: 10.1007/s10142-024-01493-x.
Metal Peroxide Nanoparticles for Modulating the Tumor Microenvironment: Current Status and Recent Prospects.
Rajaram J, Kuthati Y
Cancers (Basel). 2024; 16(21).
PMID: 39518022
PMC: 11545372.
DOI: 10.3390/cancers16213581.
Optimized full-spectrum flow cytometry panel for deep immunophenotyping of murine lungs.
Baumann Z, Wiethe C, Vecchi C, Richina V, Lopes T, Bentires-Alj M
Cell Rep Methods. 2024; 4(11):100885.
PMID: 39481389
PMC: 11705587.
DOI: 10.1016/j.crmeth.2024.100885.
Spatial Multiomics Reveals Intratumoral Immune Heterogeneity with Distinct Cytokine Networks in Lung Cancer Brain Metastases.
Christensson G, Bocci M, Kazi J, Durand G, Lanzing G, Pietras K
Cancer Res Commun. 2024; 4(11):2888-2902.
PMID: 39400127
PMC: 11539001.
DOI: 10.1158/2767-9764.CRC-24-0201.
Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance.
Shao M, Gao Y, Xu X, Chan D, Du J
Biomolecules. 2024; 14(9).
PMID: 39334866
PMC: 11430201.
DOI: 10.3390/biom14091099.